Thomas Hallam
Director of Finance/CFO presso GIVAUDAN SA
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Attualmente, Tom Hallam è direttore finanziario di Givaudan SA. Il signor Hallam è anche membro del Chartered Institute of Management Accountants. Nella sua carriera passata, il sig. Hallam è stato vicepresidente della finanza aziendale presso Serono SA. Il sig. Hallam si è laureato presso l'Università di Manchester.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GIVAUDAN SA
0.01% | 31/12/2023 | 594 ( 0.01% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Thomas Hallam
Società | Posizione | Inizio |
---|---|---|
GIVAUDAN SA | Director of Finance/CFO | 01/01/2017 |
AZELIS GROUP NV | Director/Board Member | 02/08/2022 |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Director/Board Member | - |
Precedenti posizioni note di Thomas Hallam
Società | Posizione | Fine |
---|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - |
Formazione di Thomas Hallam
The University of Manchester | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GIVAUDAN SA | Consumer Non-Durables |
AZELIS GROUP NV | Distribution Services |
Aziende private | 3 |
---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Distribution Services |
- Borsa valori
- Insiders
- Thomas Hallam